Published in J Am Acad Dermatol on August 01, 1992
Necrotizing fasciitis versus pyoderma gangrenosum: securing the correct diagnosis! A case report and literature review. Eplasty (2011) 0.97
Cutaneous manifestation of gastrointestinal disease. J Gastrointest Oncol (2016) 0.75
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry (1999) 4.22
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol (2001) 3.92
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med (1998) 3.60
The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry (1981) 3.37
The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res (1985) 3.13
Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins. J Immunol Methods (1977) 2.97
Protecting severely abused and neglected children. An unkept promise. N Engl J Med (1990) 2.58
Sterility of refrigerated injectable collagen syringes after injection of patient. J Am Acad Dermatol (1992) 2.05
An interspecific comparison of foraging range and nest density of four bumblebee (Bombus) species. Mol Ecol (2005) 2.04
A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord (1986) 1.86
Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol (1999) 1.67
The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Arch Gen Psychiatry (1997) 1.56
Duration of remission of psoriasis therapies. J Am Acad Dermatol (1999) 1.51
Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome. Arch Dermatol (1997) 1.48
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
Adaptations of the left ventricle to chronic pressure overload. Circ Res (1976) 1.44
New cutaneous manifestations of systemic diseases. Am Fam Physician (1995) 1.42
Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol (1998) 1.40
A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl) (2000) 1.39
Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. J Clin Invest (1999) 1.39
Elective use of cannula cricothyroidotomy. Anaesthesia (2011) 1.39
Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol (1998) 1.39
Atopic dermatitis. Lancet (1998) 1.37
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years. Mov Disord (1993) 1.30
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
Expression of immunoglobin G on blood lymphocytes in chronic lymphocytic leukaemia. Clin Exp Immunol (1978) 1.26
Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation (2000) 1.23
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest (1988) 1.19
Self-help activities in cocaine dependent patients entering treatment: results from NIDA collaborative cocaine treatment study. Drug Alcohol Depend (1996) 1.17
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 1.12
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol (2000) 1.11
Metastatic Crohn's disease. J Am Acad Dermatol (1984) 1.07
Diagnosis of pseudoxanthoma elasticum by scar biopsy in patients without characteristic skin lesions. N Engl J Med (1987) 1.07
Disfiguring burn scars and adolescent self-esteem. Burns (1999) 1.06
Induction of 8-oxo-7,8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells. Photochem Photobiol (1997) 1.06
Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. J Am Acad Dermatol (2001) 1.05
Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol (2001) 1.05
Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage. Free Radic Biol Med (1997) 1.00
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol (2011) 1.00
Self-help group attendance and participation among cocaine dependent patients. Drug Alcohol Depend (2000) 0.99
Benzo[a]pyrene enhances the formation of 8-hydroxy-2'-deoxyguanosine by ultraviolet A radiation in calf thymus DNA and human epidermoid carcinoma cells. Biochemistry (1998) 0.98
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol (2000) 0.97
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. J Eur Acad Dermatol Venereol (2010) 0.97
DNA structural integrity and base composition affect ultraviolet light-induced oxidative DNA damage. Biochemistry (1998) 0.96
Changes in cognition with pharmacotherapy and cognitive therapy. Br J Psychiatry (1983) 0.95
Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radic Biol Med (1999) 0.95
Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol (1993) 0.95
Calcification of elastic fibers in pseudoxanthoma elasticum. Mt Sinai J Med (1996) 0.93
The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease. Neurobiol Aging (2008) 0.92
Ingestion of dyed-opsonised yeasts as a simple way of detecting phagocytes in lymphocyte preparations. Cytophilic binding of immunoglobulins by ingesting cells. J Immunol Methods (1979) 0.92
Subcutaneous fat necrosis of the newborn with hypercalcemia. J Am Acad Dermatol (1987) 0.91
Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotype. Pediatr Dermatol (2000) 0.90
Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis (1998) 0.90
Ultraviolet radiation increases tropoelastin accumulation by a post-transcriptional mechanism in dermal fibroblasts. J Invest Dermatol (1995) 0.90
Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol (1995) 0.89
Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis (1998) 0.89
Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Cancer Res (1986) 0.89
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol (1997) 0.89
Cutaneous mycobacteriosis: occurrence and significance in two patients with the acquired immunodeficiency syndrome. Arch Dermatol (1987) 0.89
Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma. J Invest Dermatol (1985) 0.88
Differential regulation of P53 and Bcl-2 expression by ultraviolet A and B. J Invest Dermatol (1998) 0.86
High-resolution mapping and histologic examination of long radiofrequency lesions in canine atria. J Cardiovasc Electrophysiol (1999) 0.86
Leuconostoc sepsis in association with continuous enteral feeding: two case reports and a review. Pediatr Infect Dis J (1994) 0.85
Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol (1998) 0.84
Kaposi's sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases. J Am Acad Dermatol (1987) 0.84
Hopelessness and depression. Br J Clin Psychol (1983) 0.84
Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab (1991) 0.84
Combination therapy with vitamin D analogues. Br J Dermatol (2001) 0.83
Peripheral carcinoid tumours of the lung: a clinicopathological study. J Surg Oncol (1988) 0.83
Air filtration units in homes with cats: can they reduce personal exposure to cat allergen? Clin Exp Allergy (2003) 0.83
Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo. Carcinogenesis (1998) 0.83
The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol (1998) 0.81
Topical corticosteroids in psoriasis: strategies for improving safety. J Eur Acad Dermatol Venereol (2009) 0.81
Cocaine-induced mood disorder: prevalence rates and psychiatric symptoms in an outpatient cocaine-dependent sample. Am J Addict (1999) 0.81
Pseudoxanthoma elasticum and calcinosis cutis. J Am Acad Dermatol (2000) 0.81
Acne therapy: clinical pearls. Semin Cutan Med Surg (2001) 0.80
Treatment of verrucae vulgaris with alpha 2 interferon. J Infect Dis (1986) 0.80
Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis. J Am Acad Dermatol (1994) 0.80
Multiple hamartoma syndrome. J Am Acad Dermatol (1987) 0.80
Photoinduced dermal pigmentation in patients taking tricyclic antidepressants: histology, electron microscopy, and energy dispersive spectroscopy. J Am Acad Dermatol (1999) 0.80
The use of alefacept in the treatment of psoriasis. Skin Therapy Lett (2003) 0.80
Physician perceptions and experience of current treatment in actinic keratosis. J Eur Acad Dermatol Venereol (2014) 0.80
Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol (2011) 0.79
Presence of type I and VI collagen mRNAs in endothelial cells in cutaneous neurofibromas. Lab Invest (1991) 0.79
Cutaneous reactions to vitamin K1 injections. J Am Acad Dermatol (1993) 0.79
Association between acrochordons and colonic polyps. J Am Acad Dermatol (1986) 0.79
Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate. Dermatology (2005) 0.79
Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol (1998) 0.79
Determination of desmosines in elastin-related skin disorders by isocratic high-performance liquid chromatography. Exp Mol Pathol (1990) 0.79
PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2'-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells. Free Radic Biol Med (1999) 0.79
Acquired ichthyosis and hyperparathyroidism. J Am Acad Dermatol (1989) 0.79
A randomized controlled trial of a smoking cessation intervention during pregnancy. Aust N Z J Obstet Gynaecol (1999) 0.79
Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol (1989) 0.79
Cutaneous manifestations of inflammatory bowel disease. J Eur Acad Dermatol Venereol (2000) 0.78
Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins. Exp Mol Pathol (1991) 0.78
Tinea versicolor treated with terbinafine 1% solution. Int J Dermatol (1999) 0.78
Abnormalities of fibrillin in acquired cutis laxa. J Am Acad Dermatol (1994) 0.78
Interactions between tazarotene and ultraviolet light. J Am Acad Dermatol (1999) 0.77
A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. J Am Acad Dermatol (1991) 0.77
The cost of psoriasis treatment. J Eur Acad Dermatol Venereol (2001) 0.77